Workflow
ETHK链上金融生态
icon
Search documents
全球首创!华检医疗用一座大厦证明:RWA不是泡沫,而是新金融革命
Zhi Tong Cai Jing· 2025-09-21 07:05
Core Insights - The completion of the ETHK Building in Nanjing marks the establishment of the world's first core base focused on the digitalization of Real World Assets (RWA) technology, serving as a strong response to market skepticism regarding RWA's viability [1][4] - The building symbolizes a strategic transformation for the company, transitioning its brand focus from "IVD" to "ETHK Labs," highlighting its role as an enabler of global digital industry innovation and blockchain financial infrastructure [1][4] Group 1: Strategic Leap - The announcements made by the company on September 19 signify a critical leap from conceptual leadership to large-scale physical R&D and implementation [3] - The ETHK Building is not just a commercial property; it serves dual foundational missions: as a hub for physical R&D and collaborative innovation, and as a credible technology development and output infrastructure [4] Group 2: Addressing Challenges - RWA technology, which tokenizes real-world assets for blockchain integration, is becoming a vital bridge between traditional and digital finance, with a total on-chain market value of $25.93 billion as of August 15, 2025, and a 11.86% increase in asset holders [5] - The potential of RWA is hindered by several core bottlenecks, including public chain performance limitations, funding barriers between traditional and crypto worlds, complex cross-border regulations, and general liquidity issues [5] Group 3: Ecosystem Empowerment - The company's innovative "ETHK Global RWA Exchange within an Exchange" business model provides top-tier technical infrastructure and compliance support to leading enterprises across various industries, allowing for rapid entry into different sectors with strong replicability and scalability [6] - The establishment of the ETHK Building provides a physical anchor to address trust issues in the RWA sector, demonstrating the company's commitment to advancing its blockchain financial ecosystem strategy [6] Group 4: Collaborative Advantage - The company's RWA ecosystem strategy is driven by the belief that technology should serve the public good, aiming to facilitate the efficient and compliant circulation of high-quality global assets [10] - The collaboration with Renhe Pharmaceutical to establish the world's first OTC vertical RWA exchange reflects the company's innovative business model, providing tailored solutions for asset digitization and capital structure optimization [9][10] - The choice of Nanjing as the core base for RWA technology underscores strategic considerations, as the region is a hub for the biopharmaceutical industry with a mature ecosystem [9] Group 5: Industry Impact - The ETHK Building stands as a physical benchmark for the industry, representing the maturation of the RWA sector from virtual concepts to tangible, scalable implementations [11] - The partnership with Renhe Pharmaceutical is expected to introduce a "digital License-in/Out" model, breaking down traditional barriers to cross-border collaboration and enhancing innovation efficiency across the global OTC industry [10]
LOGO再度焕新背后:华检医疗(01931)的“二次创业”与万亿RWA市场的野心
Zhi Tong Cai Jing· 2025-09-20 06:23
Core Viewpoint - The announcement of the completion of the ETHK building marks a significant strategic shift for the company towards becoming a leader in the Real World Assets (RWA) digitalization space, supported by a new brand identity that reflects its commitment to blockchain technology and compliance [2][4][10]. Group 1: Strategic Infrastructure - The ETHK building is the world's first core base focused on RWA digital technology research and ecosystem empowerment, located in Nanjing with a total area of approximately 70,000 square meters [3][4]. - The building serves a dual purpose: as a physical base for research and collaborative innovation, and as a trusted technology development and output hub, expected to gather over 5,000 technical experts and R&D engineers [4][5]. Group 2: RWA Ecosystem Layout - The recent logo update and building completion represent the company's "second entrepreneurship," fully transitioning towards the RWA sector, which involves the tokenization of real-world assets [5][6]. - The RWA market is projected to reach a total locked value (TVL) of $12.5 billion by June 2025, reflecting a 124% increase from 2024, with a global market size expected to hit $16.1 trillion by 2030 [5][6]. Group 3: Innovative Business Model - The company has established a strategic partnership with Renhe Pharmaceutical to create the world's first OTC vertical RWA exchange, showcasing its innovative "exchange within an exchange" model [6][7]. - This model aims to provide on-chain financial infrastructure for leading enterprises across various industries, facilitating the tokenization of intangible assets and enhancing global asset flow [7][8]. Group 4: Value Creation and Market Impact - The company's RWA strategy aims to create multidimensional value, contributing to national strategies and public welfare, while enhancing the global OTC industry's digital transformation [8][9]. - The strategic collaboration with Renhe Pharmaceutical is expected to optimize asset structures and enable the introduction of innovative OTC products from global markets into China, benefiting both companies and consumers [8][9].
华检医疗(01931):全球首个RWA大厦-ETHK大厦正式落成 ETHK链上金融生态战略迈入实体化、规模化技术落地新纪元
Zhi Tong Cai Jing· 2025-09-19 11:49
Core Viewpoint - The completion of the ETHK Building marks a significant milestone for the company, representing the first global hub dedicated to the research and development of Real World Asset (RWA) digitalization technology, and signifies the company's commitment to advancing its ETHK blockchain financial ecosystem strategy into a new era of physical and scalable technology implementation [1][5][7] Group 1: ETHK Building Overview - The ETHK Building, located in Nanjing, covers a total area of approximately 70,000 square meters, with the main building occupying about 35,000 square meters and additional facilities including a 20,000 square meter basement [1] - It is designed to serve as the headquarters for global RWA technology research and ecosystem empowerment, featuring state-of-the-art laboratories, data centers, and collaborative office spaces [2][3] Group 2: Strategic Importance - The choice of Nanjing as the location for the ETHK Building is strategic, leveraging the city's advantages in the biopharmaceutical industry and its mature innovation ecosystem [3][4] - The building aims to facilitate deep technological collaboration with potential partners, particularly in the innovative pharmaceutical sector, by providing comprehensive digital solutions for asset digitization and tokenization [3][4] Group 3: Technological Capabilities - The ETHK Building will integrate core technology research functions, including high-performance blockchain development, cross-chain interoperability, smart contract security, and regulatory technology [2][3] - It is expected to gather over 5,000 technical experts and partners, forming one of the largest and most capable RWA research teams globally [2] Group 4: Policy and Economic Context - The building is positioned within the core area of a supportive policy environment aimed at fostering innovation in the biopharmaceutical industry, as outlined in the recent government approval for the Jiangsu Free Trade Zone [4][5] - This policy framework is anticipated to provide significant benefits in areas such as data cross-border flow and international regulatory alignment, enhancing the company's global RWA business development [5] Group 5: Future Prospects - The establishment of the ETHK Building is seen as a testament to the company's technological ambitions and its commitment to delivering innovative solutions that empower the real economy [6][7] - The company plans to leverage this strategic asset to accelerate the implementation of innovative technologies and collaborate with global partners to create a promising future [7]
华检医疗ETHK生态披露五大支柱 开辟全球资产流通新范式
Zhi Tong Cai Jing· 2025-09-14 11:47
Core Viewpoint - Huajian Medical (01931) has announced a partnership with ETHK Group to establish the "ETHK" brand, focusing on building a blockchain financial ecosystem with five core pillars [1] Group 1: Partnership and Brand Development - The collaboration aims to create the "ETHK" brand, which will serve as a foundation for a blockchain financial ecosystem [1] - The partnership emphasizes the importance of optimizing mainstream public chains and developing proprietary blockchain infrastructure [1] Group 2: Financial Product Matrix - The initiative includes a financial product matrix that covers Real World Assets (RWA) and on-chain derivatives, with a focus on promoting "on-chain stocks" and equity tokenization [1] - This approach is designed to enhance the digitalization of global assets and facilitate the connection of Chinese assets with global capital [1] Group 3: Sustainable Model and Compliance - A sustainable model will be established, incorporating transaction fees and governance token incentives [1] - The framework will also include a compliance structure for global financial licenses, ensuring regulatory adherence [1] Group 4: User Integration - The strategy will integrate fiat currency channels to provide a seamless user entry point into the blockchain financial ecosystem [1]
华检医疗(01931)ETHK生态披露五大支柱 开辟全球资产流通新范式
智通财经网· 2025-09-14 11:46
Core Viewpoint - Huajian Medical (01931) has announced a partnership with ETHK Group to develop the "ETHK" brand, focusing on building a comprehensive on-chain financial ecosystem [1] Group 1: Strategic Initiatives - The collaboration outlines five core pillars for the "ETHK" on-chain financial ecosystem: optimizing mainstream public chains and developing proprietary blockchain infrastructure [1] - The financial product matrix will cover Real World Assets (RWA) and on-chain derivatives, with a focus on promoting "on-chain stocks" and equity tokenization [1] - A sustainable model will be established that includes transaction fees and governance token incentives [1] Group 2: Regulatory and Market Integration - The partnership aims to create a compliance framework for global financial licenses [1] - It will integrate fiat currency channels to provide a seamless user entry point [1] Group 3: Market Impact - This strategic layout aims to materialize Huajian Medical's on-chain financial strategy, accelerating global asset digitization and opening new pathways for Chinese assets to connect with global capital [1]